Latest issue of Clinical laboratory
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
SignalChem enters clinical trial collaboration with Merck to evaluate effect of SLC-391 in combination with pembrolizumab in advanced NSLC
, /in E-News /by panglobalSignalChem Lifesciences, a clinical-stage company developing novel targeted therapies for oncology, is collaborating with Merck (MSD) through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC).
Phico Therapeutics awarded up to $18.2 million to advance SASPject antibacterial therapy through Phase 1 clinical trials
, /in E-News /by panglobalPhico Therapeutics, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, has been awarded a grant of up to US$18.2 million from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a global non-profit partnership dedicated to accelerating antibacterial research.
ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development
, /in E-News /by panglobalViroclinics-DDL, a Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, a bioinformatics software engineering company, have received approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application. This R&D partnership project combines ‘wet-lab’ (in vitro) diagnostic and high-throughput sequencing expertise of Viroclinics-DDL and ‘dry-lab’ (in […]
Oxford University and Prenetics collaborate to scale rapid testing tech globally
, /in E-News /by 3wmediaThe University of Oxford, Prenetics Limited, a global leader in diagnostics and genetic testing, and Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to further develop the award-winning OxLAMP technology, a rapid, molecular testing technology for infectious diseases.
Celonic Group, University College London in partnership to produce protein therapeutics using CHOvolution platform
, /in E-News /by panglobalCelonic Group, a Swiss-German contract development and manufacturing organization, and University College London (UCL), UK, have set up a partnership to enable UCL to use Celonic’s CHOvolution cell expression platform for the production of therapeutic protein candidates.
Axol Bioscience and Censo Biotechnologies merge to boost iPSC-related technologies
, /in E-News /by 3wmediaAxol Bioscience, a provider of iPSC-derived cells, media, and characterization services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies, have merged.
Aptamer Group and Mologic enter commercial partnership to develop aptamer-based SARS-CoV-2 rapid antigen test
, /in E-News /by 3wmediaAptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has entered a commercial partnership with Mologic, a leading developer and manufacturer of lateral flow and rapid diagnostic tests.
Acute Kidney Injury (AKI) Is Strongly Associated with COVID-19
, /in Advertenties /by Nova Biomedical Corp.Hemostasis automation that works on so many levels.
, /in Advertenties /by Instrumentation LaboratoryBasic Metabolic Panel. STAT.
, /in Advertenties /by Instrumentation Laboratory